1.Anysis in burden of main caregivers of patients with stroke and its influencing factors
June ZHANG ; Lie CAI ; Yongjing SU ; Fengchan ZHOU
Chinese Journal of Practical Nursing 2009;25(16):14-17
Objective To study the burden of main earegivers of patients with stroke and its influ-encing factors, besides, the corresponding nursing countermeasures were disucssed. Methods 56 main caregivers of stroke families were selected to complete caregiver burden inventory (CBI). Results The general level of burden of main caregivers was in the moderate level with score value (1.55±0.35),factors influencing the burden of caregivers included ADL index, number of caregivers who involved in nursing and hospitalization times. Conclusions Nurses should educate the stroke patients about their rehabilitation systematically to decrease the severity of stroke sequela and readmission times, besides, they should strengthen their family support to reduce the burden of caregivers and increase their health status both physically and psychologically.
2.Treating cervical cancer with radiotherapy combined with hyperbaric oxygen treatment
Daoyuan YU ; Wei ZHOU ; Jiajun CHEN ; June PANG
Chinese Journal of Physical Medicine and Rehabilitation 2003;0(08):-
Objective To explore the clinical value when treating cervical cancer of supplementing radiotherapy with hyperbaric oxygen treatment. Methods Fifty-eight cervical cancer patients were randomly divided into 2 groups; the HBO group (n=28) received radiotherapy combined with hyperbaric oxygen treatment; a control group (n = 30) received only radiotherapy. Results The complete response rate (CR) of the HBO group was 75.0% , the partial response rate (PR) was 7.1% ,the effective rate(CR + PR) was 92.8% , the total 3 year survival rate was 71.4% , the local recurrence rate was 10.7% , and all of these results were significantly different from the controls (P
3.Prevalence of vitiligo in China:an epidemiological survey in 6 provinces
Xiaoyan WANG ; Tinglin WANG ; Cheng ZHOU ; Yiwei SHEN ; Xiaolan DING ; Shan TIAN ; Ying LIU ; Guanghui PENG ; June ZHOU ; Shuqi XUE ; Renli WANG ; Ying TANG ; Xuemei MENG ; Guangde PEI ; Yunhua BAI ; Qing LIU ; Hang LI ; Juan DU ; Jianzhong ZHANG
Chinese Journal of Dermatology 2010;43(7):463-466
Objective To investigate the prevalence of vitiligo in China through a multi-center and larse-population epidemiological survey.Methods A community-based survey was conducted in 6 cities from 6 provinces.Cluster sampling method was used.Subjects were required to fulfill the self-report questionnaires and received physical examination by dermatologists.EpiData and SPSS11.5 were utilized for statistical analysis. Results Totally,19 974 patients participated in this study,and 17 345 valid questionnaires were retrieved with a return rate of 86.84%.Of them,122 were found to have vitiligo.The prevalence and standardized prevalence of vitiligo was 0.70% and 0.56% in all patients,0.95% (75) and 0.69% in male patients and 0.50% (47) and O.45% in female patients.respectively.A significant elevation was observed in the prevalence of vitiligo in males than in females (P<0.01).The prevalence of vitiligo was increased with age and peaked in patients aging from 60 to 69 years and those over 70 years.The age at onset of vitiligo varied from 0 to 19 years in 21.85% of these patients,from 20 to 49 years in 47.05%.The most connnon type was focal vitiligo,which accounted for 36.06%,while the rarest type wag segmental type (2.46%).The pesitivity rate of family history of vitiligo was 9.84% in patients and 1.31% in community population (P<0.01).About 31.97% of the patients complained of negative influence of vitiligo on quality of life.Conclusions The standardized prevalence of vitiligo is 0.56%in 6 provinces from China.Males seem to have a higher prevalence of vifiligo than females.
4.Gene Expression Profiles in Genetically Different Mice Infected with Toxoplasma gondii: ALDH1A2, BEX2, EGR2, CCL3 and PLAU.
Hassan Ahmed Hassan Ahmed ISMAIL ; Juan Hua QUAN ; Zhou WEI ; In Wook CHOI ; Guang Ho CHA ; Dae Whan SHIN ; Young Ha LEE ; Chang June SONG
The Korean Journal of Parasitology 2012;50(1):7-13
Toxoplasma gondii can modulate host cell gene expression; however, determining gene expression levels in intermediate hosts after T. gondii infection is not known much. We selected 5 genes (ALDH1A2, BEX2, CCL3, EGR2 and PLAU) and compared the mRNA expression levels in the spleen, liver, lung and small intestine of genetically different mice infected with T. gondii. ALDH1A2 mRNA expressions of both mouse strains were markedly increased at day 1-4 postinfection (PI) and then decreased, and its expressions in the spleen and lung were significantly higher in C57BL/6 mice than those of BALB/c mice. BEX2 and CCR3 mRNA expressions of both mouse strains were significantly increased from day 7 PI and peaked at day 15-30 PI (P<0.05), especially high in the spleen liver or small intestine of C57BL/6 mice. EGR2 and PLAU mRNA expressions of both mouse strains were significantly increased after infection, especially high in the spleen and liver. However, their expression patterns were varied depending on the tissue and mouse strain. Taken together, T. gondii-susceptible C57BL/6 mice expressed higher levels of these 5 genes than did T. gondii-resistant BALB/c mice, particularly in the spleen and liver. And ALDH1A2 and PLAU expressions were increased acutely, whereas BEX2, CCL3 and EGR2 expressions were increased lately. Thus, these demonstrate that host genetic factors exert a strong impact on the expression of these 5 genes and their expression patterns were varied depending on the gene or tissue.
Aldehyde Dehydrogenase/*genetics/metabolism
;
Animals
;
Brain/metabolism/parasitology
;
Chemokine CCL3/*genetics/metabolism
;
Early Growth Response Protein 2/*genetics/metabolism
;
Gene Expression Profiling
;
Humans
;
Lung/metabolism/parasitology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Mice, Inbred Strains
;
Nerve Tissue Proteins/*genetics/metabolism
;
Organ Specificity
;
Spleen/metabolism/virology
;
Toxoplasma/*physiology
;
Toxoplasmosis/*genetics/metabolism/parasitology
;
Urokinase-Type Plasminogen Activator/*genetics/metabolism